Lifecore Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
CHASKA, Minn., Jan. 16, 2026 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ:…
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard.
January 08, 2026 18:13 ET | Source: Semilux International Ltd. Taipei, Taiwan,…
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
January 02, 2026 16:05 ET | Source: Terns Pharmaceuticals, Inc. FOSTER CITY,…
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
December 19, 2025 16:15 ET | Source: Zenas BioPharma WALTHAM, Mass., Dec.…
Zevra Therapeutics Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
December 12, 2025 16:30 ET | Source: Zevra Therapeutics CELEBRATION, Fla., Dec.…
Spero Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
November 28, 2025 08:00 ET | Source: Spero Therapeutics, Inc. CAMBRIDGE, Mass.,…
InspireMD Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
November 21, 2025 09:00 ET | Source: InspireMD Inc. MIAMI, Nov. 21,…
Crinetics Pharmaceuticals Announces October 2025 Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:41 ET | Source: Crinetics Pharmaceuticals, Inc. SAN DIEGO,…
Vera Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
October 10, 2025 16:05 ET | Source: Vera Therapeutics BRISBANE, Calif., Oct.…
electroCore Announces Inducement Grant under NASDAQ Listing Rule 5635(c)(4)
ROCKAWAY, N.J., Oct. 03, 2025 (GLOBE NEWSWIRE) -- electroCore, Inc. (the “Company”),…
